专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20110212192A1 INGESTIBLES CONTAINING SUGAR AND CINNAMON OR GINSENG 审中-公开
标题翻译：含有糖，辛酸或辛辛酸的食物
公开(公告)号：US20110212192A1
公开(公告)日：2011-09-01
申请号：US13126449
申请日：2009-10-23
申请人： David Solomon , Hector J. Gomez
发明人： David Solomon , Hector J. Gomez
IPC分类号： A61K36/258 , A61K36/54 , A61K31/05 , A61K31/704 , A61P39/00
CPC分类号： A61K36/258 , A61K36/54 , A61K2300/00
摘要： A composition of ingestible ingredients containing a first ingestible ingredient which has an undesired effect on the human body when ingested, wherein preferably the ingredient is sugar and the undesired effect is blood sugar fluctuations which can lead to diabetes, and at least one other ingestible ingredient which reduces the impact or the undesired effect of the first ingestible ingredient, wherein the other ingredient is either cinnamon or polyphenols from cinnamon, or ginseng or ginsenosides from ginseng. The composition may be in a package, a bulk mix or a product.
摘要翻译：一种含有可摄入成分的可摄取成分的组合物，其在摄入时对人体具有不期望的影响，其中优选地，成分是糖，并且不期望的效果是可导致糖尿病的血糖波动，以及至少一种其它可摄入成分，减少第一种可摄入成分的影响或不期望的影响，其中另一种成分是来自肉桂的肉桂或多酚，或人参中的人参或人参皂苷。组合物可以是包装，大体积混合物或产品。

2. 发明申请

US20110212191A1 COMPOSITION FOR THE MAINTENANCE OF BLOOD SUGAR LEVELS COMPRISING CINNAMON AND GINSENG 有权
标题翻译：维生素C含量和金山含糖含量的组合物
公开(公告)号：US20110212191A1
公开(公告)日：2011-09-01
申请号：US13126097
申请日：2009-10-23
申请人： David Solomon , Hector J. Gomez
发明人： David Solomon , Hector J. Gomez
IPC分类号： A61K36/258 , A61K31/7034 , A61P25/00 , A61P25/28 , A61P3/10 , A61P9/00
CPC分类号： A61K36/258 , A61K36/54 , A61K2300/00
摘要： A composition is disclosed which comprises cinnamon or cinnamon extract such as cinnamon aqueous extract TC 112 and panax ginseng or extract from panax ginseng standardized to 1.5 to 7% ginsenosides and may comprise an artificial sweetener. The composition is embodied in the form of a pill or food product with 120 mg of cinnamon aqueous extract and 120 mg of ginseng standardized to 1 5 to 7% ginsenosides. The composition is used as a daily dosage for improvement of cognitive function, prevention or treatment of Alzheimer's disease, maintenance or lowering of blood-sugar levels, prevention of arterial disease or the improvement of cognitive function in diabetics.
摘要翻译：公开了一种组合物，其包含肉桂或肉桂提取物，例如肉桂水提取物TC 112和人参或人参标准化至1.5至7％人参皂苷的提取物，并且可以包含人造甜味剂。该组合物以具有120mg肉桂含水提取物和120mg人参标准化为15至7％人参皂甙的药丸或食品形式体现。该组合物用作改善认知功能，预防或治疗阿尔茨海默病，维持或降低血糖水平，预防动脉疾病或改善糖尿病患者的认知功能的日剂量。

3. 发明授权

US08895083B2 Composition for the maintenance of blood sugar levels comprising cinnamon and ginseng 有权
标题翻译：用于维持包含肉桂和人参的血糖水平的组合物
公开(公告)号：US08895083B2
公开(公告)日：2014-11-25
申请号：US13126097
申请日：2009-10-23
申请人： David Solomon , Hector J. Gomez
发明人： David Solomon , Hector J. Gomez
IPC分类号： A61K36/258 , A61K36/54
CPC分类号： A61K36/258 , A61K36/54 , A61K2300/00
摘要： A composition is disclosed which comprises cinnamon or cinnamon extract such as cinnamon aqueous extract TC 112 and panax ginseng or extract from panax ginseng standardized to 1.5 to 7% ginsenosides and may comprise an artificial sweetener. The composition is embodied in the form of a pill or food product with 120 mg of cinnamon aqueous extract and 120 mg of ginseng standardized to 1.5 to 7% ginsenosides. The composition is used as a daily dosage for improvement of cognitive function, prevention or treatment of Alzheimer's disease, maintenance or lowering of blood-sugar levels, prevention of arterial disease or the improvement of cognitive function in diabetics.
摘要翻译：公开了一种组合物，其包含肉桂或肉桂提取物，例如肉桂水提取物TC 112和人参或人参标准化至1.5至7％人参皂苷的提取物，并且可以包含人造甜味剂。该组合物以具有120mg肉桂水提取物和120mg人参标准化至1.5至7％人参皂甙的药丸或食品形式体现。该组合物用作改善认知功能，预防或治疗阿尔茨海默病，维持或降低血糖水平，预防动脉疾病或改善糖尿病患者的认知功能的日剂量。

4. 发明授权

US07902145B2 Terminal sterilization of injectable collagen products 有权
标题翻译：可注射胶原蛋白产品终端灭菌
公开(公告)号：US07902145B2
公开(公告)日：2011-03-08
申请号：US11383845
申请日：2006-05-17
申请人： George Chu , C. Randall Harrell , Hector J. Gomez
发明人： George Chu , C. Randall Harrell , Hector J. Gomez
IPC分类号： C12M1/12 , A61K38/00
CPC分类号： A61L2/007 , A61L2/0011 , A61L2/0035 , A61L2/0041 , A61L2/08 , A61L2202/23
摘要： Methods of sterilizing dermal fillers and injectable collagen material have been developed which reduce the level of active biological contaminants or pathogens without adversely affecting the material, i.e., wherein the dermal fillers and injectable collagen material retain their same properties before and after its terminal sterilization. In one embodiment the method for sterilizing the dermal filler or injectable collagen material that is sensitive to radiation contains the steps of protecting the filler or material from radiation, and irradiating the filler or material with a suitable dose of radiation for a time and at a rate effective to sterilize the filler or injectable material. In a preferred embodiment the method for sterilizing the dermal filler or injectable collagen material that is sensitive to radiation includes the steps of a) freezing the filler or material at a temperature below its freezing temperature, which is generally below 0° C. and b) irradiating the filler or material with a suitable dose of radiation at an effective rate for a time effective to sterilize the filler or material. The exposure of the radiation differs depending upon the density of the filler or material, but is preferably between 5 kGy and 12 kGy and more preferably between 6 kGy and 8 kGy. These doses result in a sterility assurance level (SAL) of 10−6 SAL for the filler or material.
摘要翻译：已经开发了对皮肤填充剂和可注射胶原材料进行灭菌的方法，其降低活性生物污染物或病原体的水平，而不会对材料产生不利影响，即其中真皮填料和可注射胶原材料在其终端灭菌前后保持相同的性质。在一个实施方案中，对对辐射敏感的真皮填料或可注射胶原材料进行灭菌的方法包括以下步骤：保护填料或材料免受辐射，并且以适当剂量的辐射照射填料或材料一段时间有效地对填料或可注射材料进行灭菌。在优选的实施方案中，对对辐射敏感的真皮填料或可注射胶原材料进行灭菌的方法包括以下步骤：a）在低于其冷冻温度的温度下将填料或材料冷冻，其一般低于0℃，和b）用合适剂量的辐射以有效速率照射填料或材料一段时间以有效地消除填料或材料。辐射的曝光取决于填料或材料的密度而不同，但优选在5kGy和12kGy之间，更优选在6kGy和8kGy之间。这些剂量导致填料或材料的10-6 SAL的无菌保证水平（SAL）。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式